It has also been demonstrated in non-small cell lung cancer cell lines (NSCLC) that EGFR-TKIs exert their cytotoxic effects through inhibition of the apoptosis-related protein BCL2 [57]. The gene discussed is FAM215A; the disease is non-small cell lung carcinoma.